Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
Pi‐Xiao Wang(Wuhan University), Hongliang Li(Jiangnan University)
Cited by 122
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
|Cell Metabolism|2021|223
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
|Nature Medicine|2017|187
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling
|Nature Communications|2016|182